A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease

NCT04721366 · clinicaltrials.gov ↗

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease

Interventions

OTHER: Standard of Care

Sponsor

Takeda